# 68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

> **NCT02678351** · PHASE2,PHASE3 · COMPLETED · sponsor: **Andrei Iagaru** · enrollment: 74 (actual)

## Conditions studied

- Stage II Prostate Adenocarcinoma
- Stage III Prostate Adenocarcinoma

## Interventions

- **DRUG:** 68Ga-PSMA-11
- **PROCEDURE:** Magnetic resonance imaging (MRI)
- **PROCEDURE:** Positron Emission Tomography (PET)

## Key facts

- **NCT ID:** NCT02678351
- **Lead sponsor:** Andrei Iagaru
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-18
- **Primary completion:** 2020-12-13
- **Final completion:** 2021-12
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2022-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02678351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02678351, "68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02678351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*